Standardization of allergen-specific immunotherapy vaccines.
In the 1970s and 1980s, scientific methods were introduced in the standardization of allergen vaccines and, in combination with improved documentation of the clinical benefits obtained using standardized vaccines, specific allergy treatment as a scientifically based, reproducible, and safe treatment for allergic disease was established. This article describes important issues in the control of source materials and vaccine preparation as part of the European standardization of allergen vaccines, and also includes a discussion of vaccines that are based on recombinant allergens, which may appear on the market in the near future.
Spangfort
Michael D
MD
ALK-Abelló, Bøge Allé 6-8, DK - 2970 Hørsholm, Denmark. msp@dk.alk-abello.com
Larsen
Jørgen Nedergaard
JN
D000485:Allergens / Q000276:immunology*; D003888:Desensitization, Immunologic / Q000379:methods* / Q000592:standards*; D005060:Europe; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000628:therapy*; D014612:Vaccines / Q000592:standards*
D000485:Allergens; D014612:Vaccines